Vanderbilt Amyloid Multidisciplinary Program
-
Patient’s efforts help shine light on plasma cell disorder
Charlotte Haffner, Vanderbilt’s first patient to undergo a heart transplant followed by a stem cell transplant to treat a plasma cell disorder called primary AL amyloidosis, now she dedicates her time to raising awareness about the rare disease. Read MoreApr 5, 2018
-
Multidisciplinary team takes on rare plasma cell disorder
The Vanderbilt Amyloid Multidisciplinary Program (VAMP) is a new approach to treating a rare and misunderstood disease that can kill its victims before they understand what they have been diagnosed with. Read MoreDec 6, 2012